OraSure Technologies | OSUR - 贷款资金



金融业
股票价格
USD
资产
USD 379.17M
现金及等价物
USD 176.96M
销售成本
USD 15.43M
流动资产
USD 240.78M
流动负债
USD 44.08M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 313.32M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 308.5M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 30.31M
贸易债权人
USD 10.63M
应收帐款人
USD 22.2M


贷款资金 更改 日
Agilent USD 3.05B 1000K 2026-03
AngioDynamics USD 5.6M 100K 2025-09
Becton, Dickinson and Co. USD 14.71B 2.21B 2026-03
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 802.9M 398.8M 2026-03
Bruker USD 1.66B 189.6M 2026-03
Cerus USD 64.86M 22K 2024-12
Charles River Laboratories USD 2.66B 526.77M 2026-03
Danaher USD 17.56B 855M 2026-03
Dentsply International USD 2.01B 9M 2026-03
Dexcom USD 1.3B 54.4M 2026-03
Illumina USD 1.49B 0 2026-03
Integra LifeSciences USD 1.83B 29.45M 2026-03
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 13.99B 105M 2026-03
Mesa Laboratories USD 104.2M 104.3M 2024-09
Mettler Toledo International USD 2.16B 73.35M 2026-03
Myriad Genetics USD 120.3M 400K 2026-03
OraSure Technologies USD 100K 17K 2025-12
Quidel USD 0 2.47B 2026-03
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 2.63B 836K 2026-03
STAAR Surgical USD 42K 42K 2023-12
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Trinity Biotech USD 114.86M 4.81M 2025-09
Waters USD 5.22B 3.81B 2026-03